With new Nordic and European life science funds emerging, long term specialists recharging and new players and capital from Asia and the Middle East, as well as the US, increasingly entering into deals, global syndication in the healthcare space is reforming the investment landscape. Investors discuss how the Nordic region, as a leading European hub for new science and innovation, and the companies from it can access, build and leverage an international investor base.

* Will the trend of private rounds in place of IPOs in Europe for European companies continue? Do the strong Nordic public markets factor into investment decisions?
* Will increasing interest from American and Asian funds lead to more competitive tension for deals in Europe?
* How can companies, and how will investors, be getting out and connecting internationally in the new normal?

Stephan Christgau, Partner, Eir Ventures
Rachel Mears, Partner, Jeito
Thierry Laugel, Managing Partner, Kurma Partners
Sascha Alilovic, Managing Partner, SHS
Petros Farah, VP, Vickers Venture Partners
Moderator: John Rudy, Member, Mintz

The LSX channel features sessions from LSX events, where our mission is to connect senior #biotech, #medtech & #healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

Follow us on Twitter: https://twitter.com/LSXLeaders

Like us on Facebook: https://www.facebook.com/LSXLeaders

Subscribe to our channel for more videos.

Visit us at www.lsxleaders.com